Hospital And Nursing Home Probiotics Forecast Report 2025 – Designed for Product & Growth Teams

This report is designed for companies and decision-makers seeking actionable insights on market size, growth, trends, and competitive strategies to drive expansion and success in the Hospital And Nursing Home Probiotics industry.

What is the current market size of the hospital and nursing home probiotics industry, and what growth rate is it expected to achieve?

The hospital and nursing home probiotics market size has grown rapidly in recent years. It will grow from $1.51 billion in 2024 to $1.69 billion in 2025 at a compound annual growth rate (CAGR) of 11.81%. The growth in the historic period can be attributed to increasing awareness of gut health, rising prevalence of gastrointestinal disorders, increasing adoption of probiotics in healthcare settings, growing evidence supporting the health benefits of probiotics.

The hospital and nursing home probiotics market size is expected to see rapid growth in the next few years. It will grow to $2.61 billion in 2029 at a compound annual growth rate (CAGR) of 11.44%. The growth in the forecast period can be attributed to increasing adoption of probiotics, rising demand for digestive health solutions, growing awareness of probiotics, rising focus on reducing hospital-acquired infections (HAIs), growing investments in probiotic-based medical nutrition. Major trends in the forecast period include advancements in probiotic formulations, improvements in delivery methods for targeted healthcare settings, innovations in probiotics for infection prevention, development of specialized probiotics for elderly and immunocompromised patients, and integration of digital solutions.

Download Your Free Sample PDF:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20834&type=smp

What are the major drivers contributing to the growth of the hospital and nursing home probiotics market?

The increasing prevalence of gastrointestinal disorders is expected to propel the growth of the hospital and nursing home probiotics market going forward. Gastrointestinal disorders refer to a range of conditions affecting the digestive tract, including irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), gastroesophageal reflux disease (GERD), and constipation. The rising incidence of gastrointestinal disorders is attributed to factors such as poor dietary habits, increased consumption of processed foods, sedentary lifestyles, and higher stress levels. Hospital and nursing home probiotics help manage gastrointestinal disorders by restoring the balance of beneficial gut bacteria, promoting digestive health, and alleviating symptoms such as diarrhea, constipation, and bloating. For instance, in December 2023, according to the IBD Registry, a UK-based non-profit organization, by 2023, the number of individuals with Inflammatory Bowel Disease (IBD) reached over 5,300, marking an increase of more than 3,000 members compared to 2022. Therefore, the increasing prevalence of gastrointestinal disorders is driving the growth of the hospital and nursing home probiotics market.

What are the major market segments driving the growth of the hospital and nursing home probiotics industry?

The hospital and nursing home probiotics market covered in this report is segmented –

1) By Indication: Antibiotic-Associated Diarrhea, Irritable Bowel Syndrome, Clostridium difficile Infection, Inflammatory Bowel Disease, General Gut Health

2) By Formulation Type: Capsules, Powder, Liquid, Soft Chew, Probiotic Yogurt

3) By Patient Group: Infants, Adults, Elderly, Immunocompromised Patients, Patients With Gastrointestinal Disorders

4) By Distribution Channel: Hospitals, Nursing Homes, Pharmacies, Online Retail, Healthcare Facilities

5) By Application: Gut Health, Immunity, Wellness, Other Applications

Subsegments:

1) By Antibiotic-Associated Diarrhea (AAD): Prevention of AAD, Treatment of AAD

2) By Irritable Bowel Syndrome (IBS): IBS With Diarrhea (IBS-D), IBS With Constipation (IBS-C), Mixed IBS (IBS-M)

3) By Clostridium Difficile Infection (CDI): Prevention of CDI Recurrence, Treatment Of CDI

4) By Inflammatory Bowel Disease (IBD): Crohn’s Disease, Ulcerative Colitis

5) By General Gut Health: Immune System Support, Digestive Health, Gut Microbiome Restoration

View The Full Market Report:

https://www.thebusinessresearchcompany.com/report/hospital-and-nursing-home-probiotics-global-market-report

What are the top market trends driving innovation in the hospital and nursing home probiotics industry?

Major companies operating in the hospital and nursing home probiotics market are focusing on developing innovative products such as probiotic solutions to enhance patient gut health, improve recovery times, and reduce antibiotic-associated side effects. Probiotic solutions refer to products containing live microorganisms that provide health benefits when consumed in adequate amounts, typically by improving the balance of beneficial bacteria in the digestive system. For instance, in October 2024, Probi AB, a Sweden-based biotechnology company specializing in probiotics, launched Metabolic Health by Probi for healthcare settings. metabolic health by probi is a clinically backed probiotic solution designed to support metabolic well-being, cardiovascular health, weight management, and blood pressure regulation by combining two proprietary probiotic strains, Lactiplantibacillus plantarum 299v (LP299V) and Lacticaseibacillus paracasei 8700:2 (L. Paracasei 8700:2).

Who are the key market players contributing to the growth of the hospital and nursing home probiotics industry?

Major companies operating in the hospital and nursing home probiotics market are Nestlé Health Science, BASF SE, Procter & Gamble Company, Abbott Laboratories, Lactalis Group, Danone S.A., General Mills Inc., Arla Foods Group, DuPont de Nemours Inc., Kerry Group plc, Koninklijke DSM N.V., Glanbia PLC, Yakult Honsha Co. Ltd., Chr. Hansen Holding A/S, Lallemand Inc., BioGaia AB, Klaire Labs, SymbioPharm GmbH, Synlogic Inc., Vitakem Nutraceuticals

Which regions are leading the growth of the hospital and nursing home probiotics market globally?

North America was the largest region in the hospital and nursing home probiotics market in 2024. The regions covered in the hospital and nursing home probiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Can Companies Use The Hospital And Nursing Home Probiotics Market Report to Drive Business Results?

This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:

• Time market entry or expansion using growth forecasts and CAGR trends.

• Develop competitive products by tracking key technology shifts and user preferences.

• Tailor regional strategies with in-depth geographic data and local market dynamics.

• Benchmark and plan partnerships using competitive landscape insights.

Purchase The Report And Get A Swift Delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20834

Need Customized Data On Hospital And Nursing Home Probiotics Market?

For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.

Request Customized Data:

https://www.thebusinessresearchcompany.com/customise?id=20834&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.

Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:

The Business Research Company

https://thebusinessresearchcompany.com/

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

About Top PR News

TopPRnews Leads Drives Search Engine Visibility For Your Press Release Content. Our Global Network Reaches Important Contacts, Media Partners And Websites And Journalists. Happy Postings! If You Have Any Queries Please Contact Official Mail At [kalyani@topprnews.com}

View all posts by Top PR News →